Potentially 
recipients did not enhance spontaneous tumor development. In contrast to the leukemic AKR cells that express the T-cell surface component Thy-1.1, the potential leukemic cells among bone marrow cells of young AKR mice were shown to lack the expression of this antigen. The development of preleukemic AKR marrow into overt leukemia in hybrid mice was dependent on the presence of an intact thymus and exposure of the recipients to x-rays shortly before marrow transfer. Evidently, preleukemic AKR bone marrow undergoes sequential changes, affected by host factors, leading ultimately to development of overt leukemia.
In AKR mice, leukemia develops spontaneously 6-12 months after birth. The majority of the lymphocytic neoplasms arise in the thymus and, not surprisingly, this organ has been considered as the primary site of neoplastic transformation and proliferation. However, transplantation tests have so far failed to reveal the presence of lymphomatous cells in the thymus or spleen during the first few months of life (1, 2) . The conclusion that the first fully developed lymphoma cells arise in the thymus whence they spread to other parts of the lymph system, giving rise to a generalized disease, has thus seemed justified. In line with this idea, removal of the thymus from AKR mice in the preleukemic period causes a conspicuous prolongation of life and prevents development of leukemia (3) . When neonatal thymus lobes are implanted after thymectomy, susceptibility to leukemia development is restored (4) . It has also emerged that the chronological age of thymus implants has been the determinative factor in leukemia development (5) .
In addition to the thymus having been considered as the organ providing cells most susceptible to neoplastic transformation, high titers of the leukemogenic agents known to be involved in tumor development have also been found in the organ (6) . It has been proposed that the delayed onset of leukemia is associated with the time it takes for a recombinant virus to evolve, recombination between ecotropic and xenotropic endogenous viruses being involved (7) . It has also been suggested that the thymus might also be considered as a site wherein potential leukemic cells, initially transformed in any of the hemopoietic organs, could proliferate actively into autonomous leukemic cells (4) .
Despite this apparently overwhelming evidence of the exact nature of thymic involvement, it has been shown in various leukemogenic systems in mice that premalignant cells are present in the bone marrow, and it is from these cells that the (Table 3) . Similar incidences of leukemia (mostly of AKR/J origin), with variable latent periods, were observed in the different groups tested. The lytic capacity of the antiserum used in the present experiment was indicated by its effect on leukemic cells (Table 3 ). It thus seems that preleukemic cells lack expression of 0 antigen on their cell surface. DISCUSSION Restoration of the potential to develop spontaneous or induced T-cell lymphomas in thymectomized mice by subcutaneous thymus grafting was shown to occur often through leukemic cells that emerge from the thymectomized host and repopulate the thymus graft (10) . Therefore it seems questionable whether the thymus is the sole organ capable of providing leukemic cells. Rather, the development of thymomas from host origin would suggest that the thymus provides a suitable environment for the proliferation and differentiation of lymphoid cells undergoing initial transformation in the bone marrow. The results obtained in the present studies indicate occurrence of potential leukemic cells among bone marrow cells in 14-day-old AKR/J mice. These results coincide with the findings of Legrand et al. (11) who demonstrated leukemogenic potential of AKR bone marrow in sublethally irradiated (C3H X AKR/TIALD)F1 mice. The possibility that an allogeneic effect may contribute to leukemia development in the hybrid marrow recipients is excluded by the following results: (i) elimination of T cells from the AKR marrow inoculum (responsible for the graft-versushost effect) did not reduce its leukemogenic potential; (ii) transfer of DBA/2 bone marrow into hybrid recipients did not induce development of leukemia of donor origin.
The prevention of spontaneous leukemia development in germ-free AKR mice by allogeneic DBA/2 bone marrow chimerism (12) might be due to eradication of the preleukemic cells present in the bone marrow of young AKR mice. In the same context, the efficient immunoprevention of spontaneous lymphoma development in AKR mice-by treating mice on day of birth up to 14-20 days of age with immune gamma globulin (13) The present findings indicating lack of expression of the surface component Thy-1.1 on the potential AKR leukemic cells coincide with our previous observations concerning the phenotype characteristics of preleukemic cells detected among bone marrow cells of C57BL/6 mice shortly after virus or x-ray leukemogenesis (15, 16) . Virus-induced preleukemic cells were actually shown to be committed precursor T cells (prothymocytes) (16) . These preleukemic cells would need the thymic microenvironment for further differentiation into overt T-cell leukemias. The increased level of xenotropic virus observed in the thymus of several-month-old AKR mice (17) , probably related with the age-dependent altered thymus subpopulations (18, 19) , could contribute to thymus injury and thereby cause influx of bone marrow-transformed precursor cells into the required thymus microenvironment.
The fact that proliferation of preleukemic cells, originating in the bone marrow of young AKR mice, was arrested in syngeneic mice (Table 1) in contrast to ameliorated proliferation occurring after transfer into hybrid recipients deserves special attention. Previous studies concerned with the induced T-cell leukemogenesis have provided evidence that the initial transformation of prothymocytes into preleukemic cells in itself is insufficient to cause tumor development (20) . Because preleukemic cells were shown to be immunogenic (16) it has been suggested that their proliferation is controlled through the maintenance of a host-tumor immune balance (20) . AKR mice have been shown to possess immunocompetent lymphocytes that can participate in different immune reactions (21) . Lymphoid cells from preleukemic AKR mice (3-36 weeks old) were shown to produce cytotoxic lesions to monolayers of syngeneic embryo and thymus target cells in vitro, in contrast to lack of or reduced reactivity of lymphoid cells from leukemic AKR mice (22) .
More recently, a non-T-cell spontaneous antilymphoma killing reaction has been observed in preleukemic AKR mice (23) . This antileukemic reaction was shown to be age related, maximal in 3-to 5-month-old mice and thereafter decreasing and finally disappearing with the progression of the disease. Expression of G (AKSL2) antigen and production of G (AKSL2) antibody in young AKR mice have also been observed recently (24) . It perhaps could be suggested that these different immunological reactivities observed in young AKR mice might be induced by the early-occurring preleukemic cells. This state of immunity could contribute to the long latent period characteristic of AKR leukemogenesis. The delayed occurrence of the recombinant virus (proposed as a prerequisite for overt leukemia expression) has been considered recently as a "delaying" factor in AKR leukemogenesis (6) . Because AKR mice seem to be born with potential preleukemic cells (perhaps due to a preexisting genetic loci fixed in the mouse germ line?), the recombinant virus might induce autonomous leukemic clones and thereby contribute to the transition from the dependent preleukemic state to autonomous overt development of leukemia.
